Physician
Bermudez-Emmanuelli, Rosa
Bermudez-Emmanuelli, Rosa was paid $140K by Medicaid between Mar 2018 and Mar 2024, across 17 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 27% of everything it billed.
33Billing provider infoBERMUDEZ-EMMANUELLI, ROSA
ATTLEBORO, MA 02703
ATTLEBORO, MA 02703
33aNPI1043405863assigned 09/14/2007
33bProvider typeObstetrics & Gynecology Physician
28Total paid$140K
24GClaims2,076
24DCodes billed17
24AFirst – last monthMar 2018 – Mar 2024
Compared with peers
Next to other Obstetrics & Gynecology Physician providers in Massachusetts
Rank by total paid#23 of 216
Median peer was paid$7K
This provider vs. median21×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 520 | $26K | |
| 2019 | 59 | $6K | |
| 2020 | 156 | $9K | |
| 2021 | 513 | $33K | |
| 2022 | 475 | $39K | |
| 2023 | 302 | $23K | |
| 2024incomplete | 51 | $4K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 27% | 531 | 486 | $38K |
| 88175 | Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer | 13% | 346 | 343 | $17K |
| 87624 | Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types | 10% | 206 | 202 | $14K |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | 9.7% | 169 | 160 | $13K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | 9.6% | 169 | 160 | $13K |
| 87661 | Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe | 7.4% | 166 | 159 | $10K |
| 99395 | Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years | 4.0% | 37 | 29 | $6K |
| 99396 | Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years | 3.8% | 36 | 36 | $5K |
| 59425 | 3.2% | 15 | 12 | $5K | |
| 87480 | 2.7% | 82 | 79 | $4K | |
| 87660 | 2.3% | 82 | 79 | $3K | |
| 87481 | 2.2% | 13 | 13 | $3K |
5 more codes
| 87510 | 2.1% | 70 | $3K | |
| 87801 | Infectious agent detection by nucleic acid; amplified probe, multiple organisms | 1.2% | 13 | $2K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 55 | $1K |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 24 | $685.57 |
| 81025 | <1% | 62 | $426.24 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.